Franklin Resources’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.1M Sell
347,479
-53,438
-13% -$3.43M 0.01% 922
2026
Q1
$22.6M Sell
400,917
-63,187
-14% -$4.12M 0.01% 941
2025
Q4
$37.2M Sell
464,104
-163,127
-26% -$11M 0.01% 739
2025
Q3
$30.6M Buy
627,231
+12,005
+2% +$743K 0.01% 822
2025
Q2
$45.9M Buy
615,226
+60,582
+11% +$4.01M 0.01% 651
2025
Q1
$35.2M Buy
554,644
+6,680
+1% +$454K 0.01% 721
2024
Q4
$42.8M Sell
547,964
-134,084
-20% -$10.8M 0.01% 667
2024
Q3
$51.4M Sell
682,048
-742,629
-52% -$60M 0.01% 595
2024
Q2
$118M Buy
1,424,677
+31,034
+2% +$2.73M 0.04% 377
2024
Q1
$119M Sell
1,393,643
-300,237
-18% -$23.6M 0.04% 376
2023
Q4
$145M Sell
1,693,880
-505
-0% -$43.7K 0.07% 298
2023
Q3
$152M Buy
1,694,385
+55,947
+3% +$5M 0.08% 274
2023
Q2
$139M Buy
1,638,438
+222,943
+16% +$18.8M 0.07% 304
2023
Q1
$117M Buy
1,415,495
+63,787
+5% +$5.16M 0.06% 339
2022
Q4
$106M Buy
1,351,708
+1,041
+0.1% +$83.7K 0.06% 355
2022
Q3
$100M Buy
1,350,667
+47,254
+4% +$3.39M 0.05% 371
2022
Q2
$85M Sell
1,303,413
-167,834
-11% -$9.93M 0.04% 420
2022
Q1
$93M Buy
1,471,247
+3,677
+0.3% +$200K 0.04% 453
2021
Q4
$77.8M Sell
1,467,570
-12,318
-0.8% -$751K 0.03% 522
2021
Q3
$104M Buy
1,479,888
+138,399
+10% +$8.73M 0.04% 460
2021
Q2
$89.4M Sell
1,341,489
-521,221
-28% -$36.9M 0.03% 492
2021
Q1
$207M Buy
1,862,710
+66,619
+4% +$8.24M 0.08% 262
2020
Q4
$213M Buy
1,796,091
+72,240
+4% +$7.78M 0.09% 246
2020
Q3
$150M Buy
1,723,851
+438,864
+34% +$38.4M 0.07% 284
2020
Q2
$118M Buy
1,284,987
+261,830
+26% +$26.4M 0.06% 326
2020
Q1
$102M Sell
1,023,157
-123
-0% -$13.3K 0.07% 296
2019
Q4
$118M Sell
1,023,280
-3,190
-0.3% -$386K 0.06% 334
2019
Q3
$129M Buy
1,026,470
+4,635
+0.5% +$588K 0.07% 304
2019
Q2
$123M Buy
1,021,835
+18,341
+2% +$1.8M 0.07% 315
2019
Q1
$87.8M Buy
1,003,494
+554
+0.1% +$50.4K 0.05% 392
2018
Q4
$100M Buy
1,002,940
+184
+0% +$19.3K 0.06% 329
2018
Q3
$115M Buy
1,002,756
+831
+0.1% +$86K 0.06% 345
2018
Q2
$89.9M Buy
1,001,925
+1,925
+0.2% +$163K 0.05% 392
2018
Q1
$73.2M Hold
1,000,000
0.04% 440
2017
Q4
$58.1M Hold
1,000,000
0.03% 498
2017
Q3
$44.9M Hold
1,000,000
0.02% 565
2017
Q2
$39.5M Hold
1,000,000
0.02% 598
2017
Q1
$40.6M Hold
1,000,000
0.02% 580
2016
Q4
$40.2M Hold
1,000,000
0.02% 583
2016
Q3
$36.2M Hold
1,000,000
0.02% 632
2016
Q2
$29M Hold
1,000,000
0.02% 693
2016
Q1
$35M Hold
1,000,000
0.02% 635
2015
Q4
$32.2M Hold
1,000,000
0.02% 698
2015
Q3
$32.3M Hold
1,000,000
0.02% 704
2015
Q2
$41.4M Hold
1,000,000
0.02% 668
2015
Q1
$44.9M Hold
1,000,000
0.02% 637
2014
Q4
$37.4M Sell
1,000,000
-22
-0% -$806 0.02% 702
2014
Q3
$34.9M Buy
1,000,022
+22
+0% +$785 0.02% 709
2014
Q2
$35.3M Hold
1,000,000
0.02% 716
2014
Q1
$32.6M Hold
1,000,000
0.02% 724
2013
Q4
$42.1M Hold
1,000,000
0.02% 604
2013
Q3
$39.9M Hold
1,000,000
0.02% 605
2013
Q2
$41.4M Buy
+1,000,000
New +$40.5M 0.02% 567

Other funds holding HAE

Franklin Resources's HAE Position: Q2 2026 in Review

Franklin Resources reduced its Haemonetics (HAE) stake by 13% in Q2 2026, selling an estimated $3.43M and leaving 347,479 shares worth $26.1M. The position accounts for 0.01% of the portfolio, ranked #922.

Franklin Resources first reported a position in HAE in Q2 2013 and has held it in 53 quarters since. The position peaked at $213M in Q4 2020. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Franklin Resources held 347,479 shares of Haemonetics worth $26.1M as of Q2 2026.
  • Franklin Resources sold 53,438 Haemonetics shares in Q2 2026, an estimated $3.43M.
  • Haemonetics made up 0.01% of Franklin Resources's portfolio in Q2 2026, its #922 holding.
  • Franklin Resources first reported a position in Haemonetics in Q2 2013 and has held it in 53 quarters since.
  • Franklin Resources's Haemonetics position peaked at $213M in Q4 2020.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.